Migraine and stroke: The role of oral contraceptives

Neurological Sciences

Volumn 29, Issue SUPPL. 1, 2008, Pages

  Allais, Gianni ^a   Gabellari, Ilaria Castagnoli ^a   Mana, Ornella ^a   Schiapparelli, Paola ^a   Terzi, Maria Grazia ^a   Benedetto, Chiara ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Migraine; Oral contraceptives; Stroke

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; CYTOSINE; DESOGESTREL; GESTAGEN; GESTODENE; GUANINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ORAL CONTRACEPTIVE AGENT; PROTHROMBIN; THYMINE;

ARTICLE; BLOOD CLOTTING DISORDER; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; DOSE RESPONSE; DRUG CONTRAINDICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; LONG TERM CARE; LOW DRUG DOSE; MIGRAINE; MIGRAINE WITH AURA; PATENT FORAMEN OVALE; RISK FACTOR; THROMBOSIS;

CONTRACEPTIVES, ORAL; FACTOR V; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MIGRAINE DISORDERS; RISK; STROKE;

EID: 45249123229     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0877-6     Document Type: Article

References (23)

1. Gillum LA, Mamidipudi SK, Johnston SC (2000) Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 284:72-78
2. Chan WS, Ray J, Wai EK et al (2004) Risk of stroke in women exposed to low-dose oral contraceptives: A critical evaluation of the evidence. Arch Intern Med 164:741-747
3. Baillargeon JP, McClish DK, Essah PA et al (2005) Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: A meta-analysis. J Clin Endocrinol Metab 90:3863-3870
4. World Health Organization (2004) Improving access to quality care in family planning: Medical eligibility criteria for contraceptive use, 3rd Edn. World Health Organization, Geneva
5. Slooter AJ, Rosendaal FR, Tanis BC et al (2005) Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. J Thromb Haemost 3:1213-1217
6. Pezzini A, Grassi M, Iacoviello L et al (2007) Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives. J Neurol Neurosurg Psychiatry 78:271-276
7. Henrich JB, Horwitz LA (1989) A controlled study of ischemic stroke risk in migraine patient. J Clin Epidemiol 42:733-780
8. Tzourio C, Tehindrazanarivelo A, Iglésias S et al (1995) Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 310:830-833
9. Carolei A, Marini C, De Matteis G (1996) History of migraine and risk of cerebral ischemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 347:1503-1506
10. Chang C, Donaghy M, Poulter N et al (1999) Migraine and stroke in young women: Case-control study. BMJ 318:13-18
11. Kurth T, Slomke MA, Kase CS et al (2005) Migraine, headache, and the risk of stroke in women: A prospective study. Neurology 64:1020-1026
12. Stang PE, Carson AP, Rose KM et al (2005) Headache, cerebrovascular symptoms and stroke: The Atherosclerosis Risk in Communities Study. Neurology 64:1573-1577
13. Etminan M, Takkouche B, Isorna FC et al (2005) Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ 330:63-65
14. Corral J, Iniesta JA, González-Conejero R et al (1998) Migraine and prothrombotic genetic risk factors. Cephalalgia 18:257-260
15. D'Amico D, Moschiano F, Leone M et al (1998) Genetic abnormalities of the protein C system: Shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia 18:618-621
16. Intiso D, Crociani P, Fogli D et al (2002) Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients. Neurol Sci 22:455-458
17. Kara I, Sazci A, Ergul E et al (2003) Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 111:84-90
18. Oterino A, Valle N, Bravo Y et al (2004) MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia 24:491-494
19. Lea RA, Ovcaric M, Sundholm J et al (2004) The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2:3
20. Pezzini A, Del Zotto E, Magoni M et al (2003) Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke 34:28-33
21. Anzola GP, Meneghetti G, Zanferrari C et al (2008) Is migraine associated with right-to-left shunt a separate disease? Result of the SAM study. Cephalalgia 28:360-366
22. Karttunen V, Hiltunen L, Rasi V et al (2003) Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 14:261-268
23. Botto N, Spadoni I, Giusti S et al (2007) Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 38:2070-2073